Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000318306-10-000018
Filing Date
2010-03-23
Accepted
2010-03-22 19:16:27
Documents
7
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10K a10k_123109.htm 10-K 1548825
2 RIGHTS AGREEMENT AMENDED ex_10-9.htm EX-10.9 35921
3 SUBSIDIARIES ex_21.htm EX-21 3793
4 AUDITORS CONSENT ex_23-1.htm EX-23.1 3978
5 CEO CERTIFICATION ex_31-1.htm EX-31.1 22407
6 CFO CERTIFICATION ex_31-2.htm EX-31.2 22416
7 CEO/CFO CERTIFICATION ex_32.htm EX-32 8042
  Complete submission text file 0000318306-10-000018.txt   1647008
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15771 | Film No.: 10697701
SIC: 2834 Pharmaceutical Preparations